CDER’s recent proposal to withdraw the accelerated acceptance of Makena (HPC) was dependent on a large randomized demo that unsuccessful to verify the benefit of this drug to newborns or lower the potential risk of https://lawsonmngm208209.ktwiki.com/828449/mkena_an_overview